GB202104038D0 - New compounds - Google Patents

New compounds

Info

Publication number
GB202104038D0
GB202104038D0 GBGB2104038.1A GB202104038A GB202104038D0 GB 202104038 D0 GB202104038 D0 GB 202104038D0 GB 202104038 A GB202104038 A GB 202104038A GB 202104038 D0 GB202104038 D0 GB 202104038D0
Authority
GB
United Kingdom
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2104038.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicore Pharma AB
Original Assignee
Vicore Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicore Pharma AB filed Critical Vicore Pharma AB
Priority to GBGB2104038.1A priority Critical patent/GB202104038D0/en
Publication of GB202104038D0 publication Critical patent/GB202104038D0/en
Priority to US18/283,487 priority patent/US20240174657A1/en
Priority to JP2023558499A priority patent/JP2024511452A/ja
Priority to CA3212780A priority patent/CA3212780A1/en
Priority to PCT/GB2022/050726 priority patent/WO2022200786A1/en
Priority to CN202280030667.9A priority patent/CN117203204A/zh
Priority to EP22714510.9A priority patent/EP4313976A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2104038.1A 2021-03-23 2021-03-23 New compounds Ceased GB202104038D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB2104038.1A GB202104038D0 (en) 2021-03-23 2021-03-23 New compounds
US18/283,487 US20240174657A1 (en) 2021-03-23 2022-03-23 Selective angiotensin ii receptor ligands
JP2023558499A JP2024511452A (ja) 2021-03-23 2022-03-23 選択的アンジオテンシンｉｉ受容体リガンド
CA3212780A CA3212780A1 (en) 2021-03-23 2022-03-23 Selective angiotensin ii receptor ligands
PCT/GB2022/050726 WO2022200786A1 (en) 2021-03-23 2022-03-23 Selective angiotensin ii receptor ligands
CN202280030667.9A CN117203204A (zh) 2021-03-23 2022-03-23 选择性血管紧张素ii受体配体
EP22714510.9A EP4313976A1 (en) 2021-03-23 2022-03-23 Selective angiotensin ii receptor ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2104038.1A GB202104038D0 (en) 2021-03-23 2021-03-23 New compounds

Publications (1)

Publication Number Publication Date
GB202104038D0 true GB202104038D0 (en) 2021-05-05

Family

ID=75689746

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2104038.1A Ceased GB202104038D0 (en) 2021-03-23 2021-03-23 New compounds

Country Status (7)

Country Link
US (1) US20240174657A1 (https=)
EP (1) EP4313976A1 (https=)
JP (1) JP2024511452A (https=)
CN (1) CN117203204A (https=)
CA (1) CA3212780A1 (https=)
GB (1) GB202104038D0 (https=)
WO (1) WO2022200786A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202104033D0 (en) * 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
IE20230600A3 (en) 2022-12-22 2025-09-24 Vicore Pharma Ab A method of treating a patient diagnosed with an interstitial lung disease
WO2024149712A1 (en) * 2023-01-09 2024-07-18 Vicore Pharma Ab Selective angiotensin ii compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312820A (en) 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
SE9800550D0 (sv) 1998-02-24 1998-02-24 A & Science Invest Ab A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
CA2449150C (en) 2001-05-31 2011-07-12 Vicore Pharma Ab Tricyclic compounds useful as angiotensin ii agonists
KR100938817B1 (ko) * 2001-05-31 2010-01-26 바이코어 파마 아베 안지오텐신 ⅱ 작용제로 유용한 삼중고리 화합물
WO2003064414A1 (en) * 2002-01-29 2003-08-07 Vicore Pharma Ab. Tricyclic compounds useful as angiotensin ii agonists
WO2004046141A1 (en) 2002-11-21 2004-06-03 Vicore Pharma Ab New tricyclic angiotensin ii agonists
US8835471B2 (en) 2010-06-11 2014-09-16 Vicore Pharma Ab Use of angiotensin II agonists
BR112017012337A2 (pt) 2014-12-12 2018-02-27 Vicore Pharma Ab Método para tratamento de doença falciforme, agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró- fármaco do mesmo, uso de um agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró-fármaco do mesmo, formulação farmacêutica, e, produto de combinação.
WO2016107879A2 (en) 2014-12-30 2016-07-07 Vicore Pharma Ab New use of angiotensin ii receptor agonists
CN107405406A (zh) 2015-03-02 2017-11-28 维科尔药物公司 用于治疗肺纤维化的血管紧张素ii受体激动剂
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
GB201710906D0 (en) 2017-07-06 2017-08-23 Vicore Pharma Ab Compounds and methods for treating peripheral neuropathy
GB201913603D0 (en) * 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds
GB202013721D0 (en) * 2020-09-01 2020-10-14 Vicore Pharma Ab New compounds

Also Published As

Publication number Publication date
WO2022200786A1 (en) 2022-09-29
JP2024511452A (ja) 2024-03-13
CN117203204A (zh) 2023-12-08
US20240174657A1 (en) 2024-05-30
EP4313976A1 (en) 2024-02-07
CA3212780A1 (en) 2022-09-29

Similar Documents

Publication Publication Date Title
EP4452937A4 (en) CONNECTIONS
GB202013721D0 (en) New compounds
GB202104038D0 (en) New compounds
GB202104039D0 (en) New compounds
GB202015585D0 (en) New compounds
GB202112529D0 (en) New compounds
GB202001564D0 (en) Compounds
GB202104033D0 (en) New compounds
ES3063655T3 (en) Compounds
GB202113583D0 (en) New compounds
GB202109946D0 (en) New compounds
GB202107406D0 (en) New Compounds
GB202104040D0 (en) New compounds
GB202101600D0 (en) New compounds
GB202101614D0 (en) New compounds
GB202101621D0 (en) New compounds
GB202101602D0 (en) New compounds
GB202101607D0 (en) New compounds
GB202101609D0 (en) New compounds
GB202101620D0 (en) New compounds
GB202101617D0 (en) New compounds
GB202101616D0 (en) New compounds
GB202012871D0 (en) New compounds
GB202009083D0 (en) New compounds
GB202008158D0 (en) New compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)